PT Bundamedik Tbk (IDX:BMHS)
Indonesia · Delayed Price · Currency is IDR 174.00
-5.00 (-2.79%)
Jun 11, 2026, 4:05 PM WIB
PT Bundamedik Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,606,405 | 1,614,341 | 1,554,685 | 1,488,197 | 1,658,688 | 1,890,800 | |
Revenue Growth (YoY) | 5.69% | 3.84% | 4.47% | -10.28% | -12.28% | 64.68% |
Cost of Revenue | 880,313 | 888,233 | 866,846 | 813,590 | 915,848 | 942,939 |
Gross Profit | 726,092 | 726,108 | 687,839 | 674,607 | 742,840 | 947,861 |
Selling, General & Admin | 608,939 | 607,115 | 586,546 | 581,369 | 415,685 | 405,196 |
Other Operating Expenses | 31,492 | 29,325 | 13,340 | 5,530 | 2,196 | -3,721 |
Operating Expenses | 640,431 | 636,441 | 599,885 | 586,899 | 526,419 | 472,885 |
Operating Income | 85,661 | 89,667 | 87,953 | 87,709 | 216,422 | 474,976 |
Interest Expense | -65,447 | -64,067 | -64,703 | -53,290 | -42,694 | -20,031 |
Interest & Investment Income | 22,931 | 22,931 | 18,641 | 8,424 | 8,363 | 10,178 |
Other Non Operating Income (Expenses) | -4,535 | -3,461 | -3,350 | -4,473 | -4,425 | -7,984 |
EBT Excluding Unusual Items | 38,610 | 45,071 | 38,541 | 38,369 | 177,665 | 457,139 |
Gain (Loss) on Sale of Assets | 212.15 | 212.15 | 52.94 | 1,954 | -874.84 | - |
Pretax Income | 38,822 | 45,283 | 38,594 | 40,323 | 176,790 | 457,139 |
Income Tax Expense | 14,117 | 15,610 | 19,698 | 24,094 | 47,858 | 102,490 |
Earnings From Continuing Operations | 24,704 | 29,673 | 18,896 | 16,229 | 128,932 | 354,649 |
Minority Interest in Earnings | -15,492 | -17,254 | -6,952 | -8,768 | -45,704 | -140,160 |
Net Income | 9,213 | 12,419 | 11,944 | 7,461 | 83,228 | 214,489 |
Net Income to Common | 9,213 | 12,419 | 11,944 | 7,461 | 83,228 | 214,489 |
Net Income Growth | 111.99% | 3.98% | 60.08% | -91.03% | -61.20% | 141.57% |
Shares Outstanding (Basic) | 8,361 | 8,871 | 8,531 | 8,603 | 8,603 | 8,603 |
Shares Outstanding (Diluted) | 8,361 | 8,871 | 8,531 | 8,603 | 8,603 | 8,603 |
Shares Change (YoY) | -2.02% | 3.98% | -0.84% | - | - | 314.14% |
EPS (Basic) | 1.10 | 1.40 | 1.40 | 0.87 | 9.67 | 24.93 |
EPS (Diluted) | 1.10 | 1.40 | 1.40 | 0.87 | 9.67 | 24.93 |
EPS Growth | 116.36% | - | 61.43% | -91.03% | -61.20% | -41.67% |
Free Cash Flow | 34,112 | 31,716 | -202,046 | -157,915 | -170,646 | 51,263 |
Free Cash Flow Per Share | 4.08 | 3.58 | -23.68 | -18.36 | -19.84 | 5.96 |
Dividend Per Share | - | - | 0.650 | 0.560 | 1.500 | 2.557 |
Dividend Growth | - | - | 16.07% | -62.67% | -41.34% | - |
Gross Margin | 45.20% | 44.98% | 44.24% | 45.33% | 44.79% | 50.13% |
Operating Margin | 5.33% | 5.55% | 5.66% | 5.89% | 13.05% | 25.12% |
Profit Margin | 0.57% | 0.77% | 0.77% | 0.50% | 5.02% | 11.34% |
Free Cash Flow Margin | 2.12% | 1.97% | -13.00% | -10.61% | -10.29% | 2.71% |
EBITDA | 162,304 | 170,891 | 183,039 | 182,468 | 306,066 | 537,580 |
EBITDA Margin | 10.10% | 10.59% | 11.77% | 12.26% | 18.45% | 28.43% |
D&A For EBITDA | 76,643 | 81,224 | 95,085 | 94,759 | 89,644 | 62,604 |
EBIT | 85,661 | 89,667 | 87,953 | 87,709 | 216,422 | 474,976 |
EBIT Margin | 5.33% | 5.55% | 5.66% | 5.89% | 13.05% | 25.12% |
Effective Tax Rate | 36.36% | 34.47% | 51.04% | 59.75% | 27.07% | 22.42% |
Advertising Expenses | - | 21,668 | 25,315 | 26,906 | 31,959 | 33,182 |